Burney Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,831
| Closed | -$216K | – | 594 |
|
|
2021
Q1 | $216K | Sell |
4,831
-108
| -2% | -$4.9K | 0.01% | 535 |
|
|
2020
Q4 | $227K | Sell |
4,939
-1,162
| -19% | -$53.4K | 0.01% | 485 |
|
|
2020
Q3 | $287K | Sell |
6,101
-428
| -7% | -$21.4K | 0.02% | 419 |
|
|
2020
Q2 | $333K | Sell |
6,529
-308
| -5% | -$15.8K | 0.02% | 386 |
|
|
2020
Q1 | $324K | Buy |
6,837
+393
| +6% | +$21K | 0.02% | 348 |
|
|
2019
Q4 | $379K | Buy |
6,444
+1,188
| +23% | +$66.1K | 0.02% | 367 |
|
|
2019
Q3 | $280K | Sell |
5,256
-194
| -4% | -$9.98K | 0.02% | 386 |
|
|
2019
Q2 | $273K | Sell |
5,450
-964
| -15% | -$48.4K | 0.02% | 395 |
|
|
2019
Q1 | $335K | Buy |
6,414
+1,136
| +22% | +$56.8K | 0.02% | 366 |
|
|
2018
Q4 | $252K | Buy |
5,278
+463
| +10% | +$22.8K | 0.02% | 386 |
|
|
2018
Q3 | $242K | Sell |
4,815
-596
| -11% | -$30.3K | 0.01% | 403 |
|
|
2018
Q2 | $273K | Buy |
+5,411
| New | +$273K | 0.02% | 383 |
|
|
2018
Q1 | – | Sell |
-6,778
| Closed | -$301K | – | 425 |
|
|
2017
Q4 | $301K | Buy |
6,778
+1,792
| +36% | +$82.8K | 0.02% | 343 |
|
|
2017
Q3 | $252K | Buy |
4,986
+118
| +2% | +$5.99K | 0.02% | 351 |
|
|
2017
Q2 | $263K | Sell |
4,868
-1,480
| -23% | -$78.9K | 0.02% | 342 |
|
|
2017
Q1 | $335K | Sell |
6,348
-563
| -8% | -$28.6K | 0.02% | 303 |
|
|
2016
Q4 | $333K | Sell |
6,911
-471
| -6% | -$23.3K | 0.02% | 306 |
|
|
2016
Q3 | $403K | Sell |
7,382
-208
| -3% | -$11.4K | 0.03% | 285 |
|
|
2016
Q2 | $411K | Sell |
7,590
-180
| -2% | -$9.48K | 0.03% | 285 |
|
|
2016
Q1 | $394K | Buy |
7,770
+2,958
| +61% | +$147K | 0.03% | 295 |
|
|
2015
Q4 | $246K | Buy |
+4,812
| New | +$245K | 0.02% | 330 |
|
|
2015
Q2 | – | Sell |
-6,738
| Closed | -$389K | – | 410 |
|
|
2015
Q1 | $389K | Sell |
6,738
-212
| -3% | -$12.2K | 0.03% | 313 |
|
|
2014
Q4 | $371K | Sell |
6,950
-231
| -3% | -$12.9K | 0.03% | 301 |
|
|
2014
Q3 | $413K | Sell |
7,181
-412
| -5% | -$25.3K | 0.04% | 293 |
|
|
2014
Q2 | $508K | Buy |
7,593
+1,654
| +28% | +$112K | 0.04% | 270 |
|
|
2014
Q1 | $397K | Buy |
5,939
+1,077
| +22% | +$72.8K | 0.04% | 300 |
|
|
2013
Q4 | $325K | Sell |
4,862
-556
| -10% | -$36.1K | 0.03% | 334 |
|
|
2013
Q3 | $340K | Sell |
5,418
-969
| -15% | -$62.4K | 0.04% | 321 |
|
|
2013
Q2 | $399K | Buy |
+6,387
| New | +$405K | 0.05% | 288 |
|
Other funds holding GSK
BCIM
Burney Company's GSK Position: Q2 2021 in Review
Burney Company sold out of GSK (GSK) in Q2 2021, closing a stake of 4,831 shares — an estimated $216K sold.
Burney Company first reported a position in GSK in Q2 2013 and held it in 29 quarters. The position peaked at $508K in Q2 2014. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.
- Burney Company reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
- Burney Company sold 4,831 GSK shares in Q2 2021, an estimated $216K.
- Burney Company first reported a position in GSK in Q2 2013 and held it in 29 quarters.
- Burney Company's GSK position peaked at $508K in Q2 2014.
- 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.
Based on Burney Company's 13F filing for Q2 2021, filed 6 Aug 2021.